| 000 | 02591nam a2200505 i 4500 | ||
|---|---|---|---|
| 999 |
_c279789 _d279789 |
||
| 001 | on1086345906 | ||
| 003 | OCoLC | ||
| 005 | 20190315182013.0 | ||
| 006 | m o d f | ||
| 007 | cr gn||||||||| | ||
| 008 | 190219s2019 dcua ob f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _epn _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a1019-C-01 (online) | ||
| 086 | 0 | _aY 4.C 73/8:115-87 | |
| 088 | _aSerial no. 115-87 (United States. Congress. House. Committee on Energy and Commerce) | ||
| 099 | _aY 4.C 73/8:115-87 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Oversight and Investigations, |
|
| 245 | 1 | 0 |
_aExamining concerns of patient brokering and addiction treatment fraud : _bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, December 12, 2017. |
| 264 | 1 |
_aWashington : _bU.S. Government Publishing Office, _c2019. |
|
| 300 |
_a1 online resource (iii, 188 pages) : _billustrations |
||
| 336 | _btxt | ||
| 337 |
_bc _2rdamedia |
||
| 338 |
_bcr _2rdacarrier |
||
| 500 | _a"Serial no. 115-87." | ||
| 500 | _aCRDP Program record. | ||
| 504 | _aIncludes bibliographical references. | ||
| 588 | _aDescription based on online resource; title from PDF title page (govinfo, viewed Feb. 19, 2019). | ||
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. _tExamining concerns of patient brokering and addiction treatment fraud _w(OCoLC)1085898691 |
| 856 | 4 | 0 | _uhttps://purl.fdlp.gov/GPO/gpo116348 |
| 050 | 4 |
_aKF27 _b.E5546 2017o |
|
| 650 | 0 |
_aSubstance abuse _xTreatment _xMoral and ethical aspects _zUnited States. |
|
| 650 | 0 |
_aSubstance abuse treatment facilities _xMarketing _xCorrupt practices _zUnited States. |
|
| 650 | 0 |
_aRehabilitation centers _xMarketing _xCorrupt practices _zUnited States. |
|
| 650 | 0 |
_aDrug addicts _xRehabilitation _xMoral and ethical aspects _zUnited States. |
|
| 650 | 0 |
_aAlcoholics _xRehabilitation _xMoral and ethical aspects _zUnited States. |
|
| 650 | 0 |
_aDrug addicts _xCrimes against _zUnited States. |
|
| 650 | 0 |
_aAlcoholics _xCrimes against _zUnited States. |
|
| 650 | 0 |
_aPatient advocacy _xGovernment policy _zUnited States. |
|
| 650 | 0 |
_aFraud _zUnited States _xPrevention. |
|
| 650 | 0 |
_aBrokers _xProfessional ethics _zUnited States. |
|
| 655 | 7 |
_aLegislative hearings. _2lcgft |
|
| 942 |
_2sudocs _c8 |
||